Emerging technologies such as Data Analytics/Machine Learning and Blockchain are touted to be the next big things set to revolutionise the way the pharmaceutical companies do business. Most of us are under the impression that these technologies are mutually exclusive — each having its own unique paths and used separately. However, that is not correct.

While Data science deals with utilising data for proper administration, blockchain ensures the data security with its decentralised ledger.

These technologies have vast untapped potential that can increase efficiency and enhance productivity. The question is, is there a point where these technologies can come together…


In our current environment, we need more resourceful, transformative ways to accomplish clinical research, and many pharma companies are beginning to look at blockchain as a potential solution to enable this paradigm shift. Now is the time for looking at new, creative ways to conduct clinical trials versus doing things the way they have always been done. For example, are there better ways to access information and data? The industry will reevaluate the whole infrastructure of clinical trials to become more operationally nimble by taking advantage of new opportunities afforded by technology like CTi.

What themes are set to dominate…


ClinTex is extremely proud to announce that the CTi token (CTI) is now available on KuCoin!

Image for post
Image for post

About KuCoin

Founded in September 2017, KuCoin has grown into one of the most popular crypto exchanges, and it currently provides a series of financial services including fiat-to-crypto, crypto-to-crypto, futures, staking, borrowing, token launch and more to its 6 million users across 207 countries and regions around the world. One out of four crypto holders worldwide is with KuCoin.

Deposits are open now, and trading will begin on Wednesday at 10:00am GMT.

Supported trading pairs are CTI/USDT and CTI/ETH.

CTI/USDT ➡️ https://trade.kucoin.com/CTI-USDT
CTI/ETH ➡️ https://trade.kucoin.com/CTI-ETH

Read the full official announcement by KuCoin here.

Originally published at https://clintex.io.


State-sponsored hackers from China, Russia, Iran and North Korea are currently engaged in concerted attempts to steal coronavirus vaccine secrets in what security experts describe as “an intellectual property war”.

Image for post
Image for post

They accuse hostile-state hackers of trying to obtain clinical trial results early and seize sensitive information at a time when a range of vaccines are close to being approved for the public.

Microsoft said most of the targets — located in Canada, France, India, South Korea and the United States — were “directly involved in researching vaccines and treatments for COVID-19.” It did not name the targets but said most…


Due to the success of our first CTi Token Presale, and the clear and vocal request from our community, we previously announced that we will split the remaining CTi token sale allocation into two parts.

Image for post
Image for post

Introducing the CTi Pre-Sale Fixed Swap Auction

ClinTex are delighted to announce our Tier 2 offering is now live on Bounce.Finance.

Bounce is a decentralised auction place protocol founded by Chandler Song, Co-founder and CEO of ANKR. On Bounce.Finance, anybody can swap or buy any token using the Metamask Wallet browser extension. To read more about Bounce.Finance, take a look at their Medium page here.


You spoke, we listened…

With the success of our first CTi Token Presale (which is on the verge of selling out — thank you!) and due to a clear and vocal request from our community we have decided to split the remaining CTi token sale allocation into two parts. First of which will be a 2nd Pre-Sale allocation, with a shorter vest period.

Introducing the CTi Pre-Sale Tier 2

Image for post
Image for post

In this allocation, 26,666,667 CTi tokens from the main sale allocation will be available at USD 0.075c. This is higher than the Tier 1 Pre-Sale, but comes with a shorter lock-up period.

For token buyers in this round, half of their…


The volume and speed of data generation during the COVID-19 pandemic is unprecedented. This mountain of data is growing daily. The massive COVID-19 Open Research Dataset (CORD-19) has been assembled from tech giants like Microsoft, the Allen Institute for Artificial Intelligence, and Georgetown University’s Center for Security and Emerging Technology . This dataset houses over 12,000 full text articles in “machine-readable form” that can be ingested programmatically into computer software programs and analyzed using machine learning applications like natural language processing (NLP). Furthermore, CovidSurg is a global registry for tracking outcomes in COVID-19 infected surgical patients with over 100 countries…


Encouraging new research suggests rapidly decreasing antibody levels don’t necessarily limit the effectiveness of potential vaccines

While the media have been awash with doomsday reports that an effective COVID-19 vaccine is hopeless due to the seemingly despairing rate at which people’s immune response to the virus dissipates over time, two recent peer-reviewed papers provide increasingly strong support for the notion that an effective vaccine is, indeed, possible.

The two papers focus on T-cells (which play a central role in the body’s immune response system), comparing their presence in people infected with either SARS-CoV 2 (the virus which causes COVID-19) or…


When a global pandemic such as COVID 19 brings the world to a standstill, the importance of the work of healthcare professionals and the pharma industry are thrust immediately into public attention. Now the world is watching and reading every news report regarding the race to find a vaccine. The importance of research and clinical drug trials have never before been so at the forefront of public minds. So too are the frustrations and limitations currently being faced by pharmaceutical companies conducting these clinical trials.

Image for post
Image for post

Clinical trials must be carried out in order to determine the safety and efficacy of…


ClinTex is pleased to announce that we have successfully completed the third-party audit of our CLI token smart contracts. These are the contracts that govern the issuance and redemption of the CLI token, define the maximum supply of tokens, and include protocols for the vesting schedule.

The smart contract audit was carried out by Beosin, a global leader in blockchain security. Headquartered in Chengdu, it is the first company in China to apply formal verification technology to the blockchain security field. Beosin has performed security audits for the likes of Huobi, OKEx, ONT, and Wanchain, and has received strategic equity…

Clintex CTi

Clinical Trials Intelligence is a data management software solution for the clinical trials industry that leverages distributed ledger technology

Get the Medium app

A button that says 'Download on the App Store', and if clicked it will lead you to the iOS App store
A button that says 'Get it on, Google Play', and if clicked it will lead you to the Google Play store